Guardant Health (GH) Debt to Equity (2015 - 2026)

Guardant Health (GH) debt to equity from Dec 31, 2015 to Mar 31, 2026. The current Guardant Health (GH) debt to equity is -830.33%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Debt to Equity

Annual Debt to Equity change of Guardant Health (GH)

Year	Debt to Equity	Change
2025	-1514.45%	+85.11%
2024	-818.15%	N/A
2023	0.00%	N/A
2022	0.00%	N/A
2021	0.00%	N/A
2020	0.00%	N/A
2019	0.00%	N/A
2018	0.00%	N/A
2017	0.00%	N/A
2016	0.00%	N/A
2015	0.00%	N/A

Comparison Guardant Health (GH) debt to equity with competitors

Guardant Health (GH) debt to equity is -830.33%.

Ticker	Name	Debt to Equity	Upside
CRL	Charles River Laboratories International Inc	0.23%	-100.03%
OPK	Opko Health Inc	0.29%	-100.04%
PRPO	Precipio Inc	0.49%	-100.06%
CSTL	Castle Biosciences Inc	2.18%	-100.26%
NTRA	Natera Inc	4.53%	-100.55%
APDN	Applied Dna Sciences Inc	4.60%	-100.55%
DGX	Quest Diagnostics Inc	6.83%	-100.82%
PRPH	ProPhase Labs Inc	7.54%	-100.91%
BLLN	Billiontoone Inc - Class A	17.80%	-102.14%
IDXX	Idexx Laboratories Inc	28.91%	-103.48%
ICLR	Icon Plc	31.25%	-103.76%
WAT	Waters Corp	31.75%	-103.82%
DHR	Danaher Corp	34.91%	-104.20%
MYGN	Myriad Genetics Inc	35.66%	-104.29%
WGS	GeneDx Holdings Corp - Class A	38.06%	-104.58%
NEO	Neogenomics Inc	40.86%	-104.92%
QGEN	Qiagen NV	43.79%	-105.27%
RVTY	Revvity Inc	44.66%	-105.38%
A	Agilent Technologies Inc	47.11%	-105.67%
ADPT	Adaptive Biotechnologies Corp	60.35%	-107.27%
LH	Laboratory Corp Of America Holdings	72.57%	-108.74%
TMO	Thermo Fisher Scientific Inc	88.65%	-110.68%
RDNT	Radnet Inc	100.55%	-112.11%
XGN	Exagen Inc	158.47%	-119.09%
IQV	IQVIA Holdings Inc	254.51%	-130.65%
SHC	Sotera Health Company	343.50%	-141.37%
NOTV	Inotiv, Inc. Common Stock	532.33%	-164.11%
BDSX	Biodesix Inc	547.55%	-165.94%